SAN DIEGO, Sept. 17, 2012 /PRNewswire/ — Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that portfolio company Red Dice Holdings President Tripp Keber, will appear on “In The Lobby” at 4pm MST this evening on

Mr. Keber will be talking about new developments at the company including the highly successful launch of Dixie X, the company‚Äôs new line of Hemp-based, CBD health and wellness products. As reported in last week’s September 13 Los Angeles Times story, CBD products have tremendous potential to help patients suffering from epilepsy and several other medical conditions.

In The Lobby is designed to give listeners a better understanding of the political, legislative, and regulatory processes that citizens are involved with. Led by Corky Kyle, it specialized in getting citizens, associations, and businesses involved in the political process.
Listen to the full interview at this link:

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company’s website at:


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
AIM: SmallCapVoice7

SOURCE Medical Marijuana Inc.